Michael Mortimore

Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents

Jean‐Damien Charrier, Steven J. Durrant, Julian M.C. Golec et al. · Journal of Medicinal Chemistry · 2011 · 259 citations · Full text

Life Sciences, Medicinal Chemistry, Oncology +15

Biogenetically Inspired Approach to the <i>Strychnos </i>Alkaloids. Concise Syntheses of (±)-Akuammicine and (±)-Strychnine

Masayuki Ito, Cameron W. Clark, Michael Mortimore et al. · Journal of the American Chemical Society · 2001 · 159 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

Characterization of a selective and potent antagonist of human P2X₇receptors, AZ11645373

Leanne Stokes, Lindsay B. Alcaraz, Julian Bent et al. · British Journal of Pharmacology · 2006 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The discovery of the potent aurora inhibitor MK-0457 (VX-680)

David Bebbington, Hayley Binch, Jean‐Damien Charrier et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 99 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Unified strategy for synthesis of indole and 2-oxindole alkaloids

Stephen F. Martin, J. E. Hunter, B. BENAGE et al. · Journal of the American Chemical Society · 1991 · 88 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10